" Entheon Biomedical (CSE:ENBI) subsidiary enters agreement with Psychedelics Today
Entheon Biomedical Corp. (ENBI) has entered into an agreement with Psychedelics Today, LLC to drive awareness for the Psychedelics Genetic Test Kit.
" Optimi Health (CSE:OPTI) submits psilocybin formulation for patent
Optimi Health Corp. (OPTI) has submitted a second patent for a two-part processing method involving the extraction and delivery of psilocybin active components.
" Red Light Holland (CSE:TRIP) collaborates with Psychedelic Medicine Alliance to legalize psilocybin in Washington State
Red Light Holland (TRIP) is collaborating with Psychedelic Medicine Alliance Washington to promote a psilocybin legalization bill in Washington State.
" Red Light Holland (CSE:TRIP) completes second evaluation of psilocybin truffles
Red Light Holland (TRIP) has received the second report for its psilocybin truffles from a Health Canada-approved laboratory.
" Entheon Biomedical (CSE:ENBI) provides update on DMT Human Trial
Entheon Biomedical (ENBI) has provided an update on its DMT human trial and regulatory submission to the BEBO ethics committee.
" Entheon Biomedical (CSE:ENBI) psychedelics genetic test now available
Entheon Biomedical Corp.’s (ENBI) expanded psychedelics genetic testing panel is now available for sale in Canada and the United States.